跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
therapeutic peptide
首页
药物
therapeutic peptide
therapeutic peptide
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
USE OF A PEPTIDE AS A THERAPEUTIC AGENT
US 2010204090 A1
申请人: BEVEC DORIAN
优先权: 2007
US
10 件公开
US 2010210534 A1
申请人: BEVEC DORIAN
优先权: 2007
US
9 件公开
US 2010286029 A1
申请人: BEVEC DORIAN
优先权: 2007
US
9 件公开
US 2010210556 A1
申请人: MONDOBIOTECH LAB AG
优先权: 2007
US
7 件公开
US 2010204150 A1
申请人: BEVEC DORIAN
优先权: 2007
US
6 件公开
US 2010256043 A1
申请人: BEVEC DORIAN
优先权: 2007
US
4 件公开
US 2010184676 A1
申请人: BEVEC DORIAN
优先权: 2007
US
4 件公开
US 2010204140 A1
申请人: BEVEC DORIAN
优先权: 2007
US
4 件公开
US 2010204157 A1
申请人: BEVEC DORIAN
优先权: 2007
US
4 件公开
US 2010234306 A1
申请人: BEVEC DORIAN
优先权: 2007
US
4 件公开
US 2010204110 A1
申请人: BEVEC DORIAN
优先权: 2007
US
3 件公开
US 2010204136 A1
申请人: BEVEC DORIAN
优先权: 2007
US
2 件公开
US 2010249019 A1
申请人: BEVEC DORIAN
优先权: 2007
US
US 2010184678 A1
申请人: BEVEC DORIAN
优先权: 2007
US
US 2010204129 A1
申请人: BEVEC DORIAN
优先权: 2008
US
Methods and compositions for oral administration of protein and peptide therapeutic agents
US 8936786 B2
申请人: VOL ALEXANDER
优先权: 2008
EP
US
WO
7 件公开
PEPTIDE COMPOUNDS AND THERAPEUTIC USES OF SAME
EP 4566617 A3
申请人: IMMUNITY PHARMA LTD
优先权: 2018
EP
US
WO
7 件公开
MODIFIED THERAPEUTIC AGENTS, STAPLED PEPTIDE LIPID CONJUGATES, AND COMPOSITIONS THEREOF
EP 4212180 A1
申请人: SCRIPPS RESEARCH INST
优先权: 2013
EP
US
7 件公开
PEPTIDE MODULATORS OF THE INTERACTION BETWEEN HUMAN C-PEPTIDE AND HUMAN ELASTIN RECEPTOR FOR THERAPEUTIC USE
US 2022009988 A1
申请人: BIOTEMPT BV
优先权: 2017
EP
US
WO
6 件公开
THERAPEUTIC PEPTIDE-POLYMER CONJUGATES, PARTICLES, COMPOSITIONS, AND RELATED METHODS
EP 2605797 A2
申请人: CERULEAN PHARMA INC
优先权: 2010
CN
EP
US
WO
5 件公开
THERAPEUTIC USE OF CALCIUM-ACTIVATED CHLORIDE CHANNEL PEPTIDE ACTIVATOR
US 2023242610 A1
申请人: CENTRE NAT RECH SCIENT
优先权: 2020
CN
EP
US
WO
5 件公开
THERAPEUTIC PEPTIDE FORMULATIONS
EP 4267104 A1
申请人: LILLY CO ELI
优先权: 2020
CN
EP
US
WO
5 件公开
FUSION PEPTIDE THERAPEUTIC COMPOSITIONS
US 2011039776 A1
申请人: CHILKOTI ASHUTOSH
优先权: 2006
CN
US
5 件公开
Glucagon-like peptide-2 and its therapeutic use
US 7049284 B2
申请人: ONTARIO INC 1149336
优先权: 2002
US
5 件公开
第 1 / 9 页
上一页
下一页
药物
反馈